Diaceutics (LON:DXRX) Trading Down 2.9% – Here’s What Happened

Diaceutics PLC (LON:DXRX) traded down 2.9% during mid-day trading on Monday . The stock traded as low as GBX 107.84 ($1.37) and last traded at GBX 107.84 ($1.37). 168,117 shares changed hands during mid-day trading, an increase of 49% from the average session volume of 112,892 shares. The stock had previously closed at GBX 111.05 ($1.41).

Wall Street Analyst Weigh In

DXRX has been the topic of several research reports. Canaccord Genuity Group restated a “buy” rating and set a GBX 160 ($2.04) price objective on shares of Diaceutics in a research report on Tuesday, December 17th. Canaccord Genuity Group reaffirmed a “buy” rating and set a GBX 160 ($2.04) price objective on shares of Diaceutics in a research report on Tuesday, December 17th.

Diaceutics Trading Up 1.9 %

The firm has a market capitalization of £92.83 million, a P/E ratio of -32.62 and a beta of 0.58. The stock’s 50-day simple moving average is GBX 132.37 and its two-hundred day simple moving average is GBX 129.75. The company has a debt-to-equity ratio of 0.39, a current ratio of 4.85 and a quick ratio of 9.92.

Insider Buying and Selling at Diaceutics

In other news, insider Graham Paterson bought 11,643 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The stock was bought at an average price of GBX 138 ($1.76) per share, with a total value of £16,067.34 ($20,452.32). Company insiders own 34.30% of the company’s stock.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.